PR PolyResearch

Join Free

NASDAQ

Estrella Immunopharma, Inc. - Warrant (ESLAW)

♥ 573 Thanks from members

Estrella Immunopharma (ESLA/ESLAW) faces severe liquidity constraints, a Nasdaq minimum bid warning, and going concern risks, even as its ARTEMIS T-cell therapies (EB103, EB104) advance in clinical trials.

No chart available for this instrument.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)